Living up to the hype around GLP-1 obesity treatments is tough enough. But Eli Lilly needs to hit its own targets.
Related Posts
Disney and Universal sue AI image company Midjourney for unlicensed use of Star Wars, The Simpsons and more
Disney and Universal have sued artificial intelligence image creator Midjourney, alleging copyright infringement, according to court filings.
Stocks making the biggest moves midday: Circle, Visa, Carnival, Halliburton, Adobe and more
These are the stocks posting the largest moves in midday trading.
‘Everyone is calling’: Trump’s tariff threats send U.S. companies scrambling for lobbyists and loopholes
Donald Trump campaigned on hardline tariff proposals that alarmed economists, corporate America and Wall Street.